Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Heo M et al. |
A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index an waist circumference.
|
|
2 |
El-Nezami H et al. |
Binding rather than metabolism may explain the interaction of two food-grade lactobacillus strains with zearalenone and its derivative alfa-zearalenol.
|
|
3 |
El-Nezami H et al. |
Probiotic bacteria-mycotoxins interactopns: an approach to enhance food safety.
|
|
4 |
El-Nezami HS et al. |
Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium.
|
|
5 |
Eriksson JG et al. |
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
|
|
6 |
Erkkilä A, Uusitupa M. |
N-3-sarjan rasvahapot suojaavat sepelvaltimotautipotilasta äkkikuolemalta.
|
|
7 |
Erkkilä AT et al. |
Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
|
|
8 |
Erkkilä AT et al. |
Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.
|
|
9 |
Gråsten SM et al. |
Fibers with different solubility characteristics alter similarly the metabolic activity of intestinal microbiota in rats fed cereal brans and inulin.
|
|
10 |
Gylling H, Miettinen TA. |
Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients.
|
|
11 |
Gylling H, Miettinen TA. |
LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
|
|
12 |
Gylling H, Miettinen TA. |
Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption.
|
|
13 |
Gylling H, Miettinen TA. |
Combination therapy with statins.
|
|
14 |
Gylling H, Miettinen TA. |
Kolesterolin aineenvaihdunnan periytyvyys.
|
|
15 |
Gylling H et al. |
Lääkevahinkovakuutuksesta korvatut lääkevahingot vuosina 1990-2000.
|
|
16 |
Gylling HK, Miettinen TA. |
Clinical experience: studies with HMG-CoA reductase inhibitors.
|
|
17 |
Haapala I et al. |
Anthropometry, bioelectrical impedance and dual-energy X-ray absorptiometry in the assessment of body composition in elderly Finnish women.
|
|
18 |
Hallikainen M et al. |
Short-term LDL cholesterol-lowering efficacy of plant stanol esters.
|
|
19 |
Hendolin M, Uusitupa M. |
Ravintotekijät säätelevät geenien toimintaa.
|
|
20 |
Janatuinen EK et al. |
No harm from five year ingestion of oats in coeliac disease.
|
|
21 |
Juntunen KS et al. |
Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects 1-3.
|
|
22 |
Karvonen HM et al. |
Effect of alfa-linolenic acid-rich camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects.
|
|
23 |
Karvonen HM et al. |
The effect of vegetable oil-based cheese on serum total and lipoprotein lipids.
|
|
24 |
Kastarinen MJ et al. |
Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland.
|
|
25 |
Knekt P et al. |
Flavonoid intake and risk of chronic diseases.
|
|
26 |
Koikkalainen M et al. |
Changes in eating and weight control habits after myocardial infarction.
|
|
27 |
Kolehmainen M et al. |
Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss.
|
|
28 |
Korhonen M. |
Dietary Treatment of Elevated Blood Pressure.
|
|
29 |
Lindi VI et al. |
Association of the Pro12Ala polymorphism in the PPAR-gamma2 with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
|
|
30 |
Louheranta A. |
Impact of Dietary Fat on Insulin Sensitivity, Glucose Metabolism, Serum Lipids and Coagulation Factors.
|
|
31 |
Louheranta AM et al. |
Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance 1-3.
|
|
32 |
Martikainen T, Gylling H. |
Lihavuuden konservatiivisen hoidon tuloksellisuus.
|
|
33 |
Miettinen TA, Gylling H. |
Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients.
|
|
34 |
Mitrunen K et al. |
Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.
|
|
35 |
Rissanen A, Uusitupa M. |
Lihavuus ja ahmimishäiriö.
|
|
36 |
Rissanen P. |
Weight Loss and Fat Distribution in Obese Women.
|
|
37 |
Schwab U et al. |
Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjets 1,2,3.
|
|
38 |
Schwab US et al. |
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprantial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
|
|
39 |
Simonen P et al. |
Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes.
|
|
40 |
Simonen PP et al. |
Body weight modules cholesterol metabolism in non-insulin dependent type 2 diabetes.
|
|
41 |
Simonen PP et al. |
Diabetes contributes to cholesterol metabolism regardless of obesity.
|
|
42 |
Uusitupa M. |
Lifestyle intervention in the prevention of type 2 diabetes.
|
|
43 |
Uusitupa M. |
Lifestyles matter in the prevention of type 2 diabetes.
|
|
44 |
Valle TT et al. |
Elämäntapamuutokset tehokkaita tyypin 2 diabeteksen ehkäisyssä. Diabetes prevention study, DPS.
|
|
45 |
Vanhanen H et al. |
Hyperkolesterolemian yhdistelmähoito.
|
|
46 |
Voutilainen-Kaunisto R et al. |
Iris transluminance in type 2 diabetes.
|
|
47 |
Vuorio AF et al. |
Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns.
|
|
48 |
Yli-Jokipii KM et al. |
Triacylglycerol molecular weight and to a lesser extent, fatty acid positional distribution, affect chylomicron triacylglycerol composition in women.
|